A Study to Evaluate Safety and Immunogenicity of the ExPEC4V Clinical Trial Material After a Single Intramuscular Dose and a Second Dose 6 Months Later in Healthy Participants Aged 18 Years and Older
Clinical trial NCT03500679 · COMPLETED
Trial details
- NCT number
- NCT03500679
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-09
- Primary completion
- 2018-11-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.